Nursing Management of Irritable Bowel Syndrome (IBS) 2008
Not Applicable
Completed
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Behavioral: Usual Care (Control Group)Behavioral: Comprehensive Self-Management (CSM)
- Registration Number
- NCT00907790
- Lead Sponsor
- University of Washington
- Brief Summary
The aim of this study is test the efficacy of a comprehensive self-management therapy to decrease abdominal pain/discomfort and improve quality of life in patients with irritable bowel syndrome (IBS) compared to IBS patients receiving their usual care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 92
Inclusion Criteria
- Men and women must be: 18-70 years old, have had symptoms of Irritable Bowel Syndrome (IBS) at least 6 mo prior to their diagnosis, and have had their diagnosis for at least 6 months, and the diagnosis had to be made by a health care provider (e.g., internist, gastroenterologist, family, nurse practitioner, physician assistant).
- In addition, the subjects must be experiencing IBS symptoms as described in the Rome-III criteria.161 That is recurrent abdominal pain or discomfort at least 3 days a mo in the last 3 mo associated with 2 or more of the following: improvement with defecation, onset associated with a change in frequency or form (appearance) of their stool.
- Adults 50 or older must have a negative colonoscopy, sigmoidoscopy, abdominal ultrasonography, or barium enema.
- Anyone with a "red flag" symptom (e.g., lost 10 lbs without trying, blood in stool, anemia) will be contacted for additional clarification.
Read More
Exclusion Criteria
- Participants will be excluded if they are taking the following medications: antibiotics, daily use of anticholinergics, tricyclic antidepressants, calcium-channel blockers
- Have a medical history of abdominal surgery (except appendectomy, Caesarian section, tubal ligation, laparoscopic cholecystectomy, hysterectomy, or abdominal wall hernia repair)
- Active organic GI disease, gluten intolerance (celiac disease), or chronic moderate to severe pain condition (e.g., low back pain, fibromyalgia)
- Recent travel to regions with endemic parasitic diseases
- Current mental health disorders (psychosis, bipolar disorder, current moderate to severe depressive episode, suicide attempt, drug or alcohol abuse or dependence within 2yrs)
- Cardiac valvular disease, immune compromised immunologic disorders (e.g., autoimmune conditions)
- Women who are pregnant, breast feeding, or planning to get pregnant in the next year
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Usual Care (Control Group) Usual Care (Control Group) Includes the usual care provided by the person and their health care provider. Comprehensive Self-Management (CSM) Comprehensive Self-Management (CSM) Comprehensive Self-Management includes 8 sessions that cover education, diet, relaxation training, and cognitive behavioral strategies as they related to symptoms of IBS --------------------------------------------------------------------------------
- Primary Outcome Measures
Name Time Method Daily abdominal pain Baseline, three and six months post randomization IBS Quality of Life Questionnaire Baseline, three and six months post randomization
- Secondary Outcome Measures
Name Time Method Salivary cortisol Baseline, three and six months post randomization Interleukin-10(IL-10) and Interleukin-12(IL-12) Baseline, three and six months post randomization Fecal calprotectin Baseline, three and six months post randomization Intestinal permeability (urine) Baseline, three and six months post randomization Brief Symptom Inventory Baseline, three and six months post randomization Cognitive Scale for Functional Bowel Disorders Baseline three and six months post randomization Work Productivity & Activity Impairment Baseline, three and six months post rand Daily symptoms(other GI and psychological) Baseline, three and six months post randomization
Trial Locations
- Locations (1)
University of Washington
🇺🇸Seattle, Washington, United States